chr7-114426617-T-C
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2
The NM_014491.4(FOXP2):āc.106T>Cā(p.Ser36Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000993 in 1,611,516 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_014491.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000198 AC: 3AN: 151654Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000160 AC: 4AN: 249526Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 134826
GnomAD4 exome AF: 0.00000890 AC: 13AN: 1459862Hom.: 0 Cov.: 31 AF XY: 0.00000964 AC XY: 7AN XY: 726258
GnomAD4 genome AF: 0.0000198 AC: 3AN: 151654Hom.: 0 Cov.: 32 AF XY: 0.0000405 AC XY: 3AN XY: 74038
ClinVar
Submissions by phenotype
Childhood apraxia of speech Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Pittsburgh Clinical Genomics Laboratory, University of Pittsburgh Medical Center | Feb 21, 2024 | This sequence variant is a single nucleotide substitution (T>C) at position 106 of the coding sequence of the FOXP2 gene that results in a serine to proline amino acid change at residue 36 of the forkhead box P2 protein. This variant is absent from ClinVar and is present in 7 of 401180 alleles (0.0017%) in the gnomAD population dataset. To our knowledge, this variant has not been observed in an individual affected by a FOXP2-related disorder in the published literature. Multiple bioinformatic tools predict that this amino acid change would be damaging, and the Ser36 residue at this position is highly conserved across the vertebrate species examined. Studies examining the functional consequence of this variant have not been published, to our knowledge. At this time, there is insufficient evidence to determine if this variant is pathogenic or benign. Therefore, we consider this a variant of uncertain significance. ACMG Criteria: PM2, PP3 - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 19, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at